ESTRO 2020 Abstract Book

Presidential Symposium Presidential symposium: Translating research and partnership into optimal health ................................ (Abs. 128-131) Symposium MR-guided Radiotherapy: state of the art and future perspectives ............................................................. (Abs. 132-134) Hypoxia-activated prodrugs: is there a future? .............................................................................................. (Abs. 135-138) Multimodal approaches in oligometastatic prostate disease: state-of-the-art ........................................... (Abs. 139-142) Debate This house believes that hippocampus avoiding whole brain irradiation is the current standard of care ........................................................................................................................ (Abs. 143-146) Symposium Surface guided radiation therapy .................................................................................................................... (Abs. 147-149) «Big data» approaches to quality improvement ............................................................................................ (Abs. 150-152) Radiotherapy: it´s all about the heart ............................................................................................................. (Abs. 153-155) Poster Highlights Poster highlights 5 CL : GI ................................................................................................................................. (Abs. 156-162) Poster highlights 6 RTT: Optimising techniques for breast and H&N RT ..................................................... (Abs. 163-169) Poster discussion CL: CNS ............................................................................................................................................................... (Abs. 170-175) CL: Breast 1 ........................................................................................................................................................ (Abs. 176-181) PH: Dose measurement and dose calculation ................................................................................................ (Abs. 182-187) PH: Treatment planning: applications 1 .......................................................................................................... (Abs. 189-193) Award Lecture E. van der Schueren Award Lecture .........................................................................................................................(Abs. 194) Jens Overgaard Legacy Award ..................................................................................................................................(Abs. 195) Proffered Papers Proffered papers 8: Cardiac toxicity ................................................................................................................ (Abs. 196-201) Proffered papers 9: Radiation effects on stem cells and the microenvironment ....................................... (Abs. 202-207) Proffered papers 10: Prostate .......................................................................................................................... (Abs. 208-213) Proffered Papers Proffered papers 11: Dose calculation for advanced techniques ................................................................. (Abs. 214-219) Proffered papers 12: Artificial Intelligence and automation ......................................................................... (Abs. 220-225) Proffered papers 13: Lung ................................................................................................................................ (Abs. 226-231) Poster Highlights Poster highlights 7 RB: Novel radiobiological targets .................................................................................... (Abs. 232-237) Poster highlights 8 PH: Planning and validation of ion beams ..................................................................... (Abs. 238-244) Teaching Lecture How can Artificial Intelligence improve contouring?. .............................................................................................(Abs. 245) How does radiotherapy change the tumour ecosystem........................................................................................(Abs. 246) Oligometastatic cancer scenarios: from biology to treatments. ...........................................................................(Abs. 247) Bladder conservation strategies...............................................................................................................................(Abs. 248) Radiosurgery: potential and pitfalls. ........................................................................................................................(Abs. 249) Dose calculation in external beam radiotherapy: The radiation transport equation and dose-to-water vs. dose-to-medium issues.......................................................................................................(Abs. 250) Patient empowerment in radiotherapy....................................................................................................................(Abs. 251) Joint Symposium ESTRO-ASTRO: Patient reported outcomes in radiation oncology - time to make them mandatory in clinical practice?................................................................................................................ (Abs. 252-255) Symposium Emerging links between radiation-induced anti-tumor immune effects and DNA damage repair signaling................................................................................................................................................... (Abs. 256-259)

SUNDAY 29 NOVEMBER 2020